Korro Bio (NASDAQ:KRRO) used its Analyst Day to outline the rationale and development plans for KRRO-121, an RNA-editing therapeutic candidate the company believes could provide a new approach to ...

While the fabled fountain of youth may not actually exist, a new type of therapy now does.

Moderna, Inc. vs. Novavax, Inc.: cost cuts, vaccine pipeline catalysts, and valuations. Click for this comparison of NVAX and ...

An experimental drug custom-made to target the genetic mutations of individual tumors showed promise in treating aggressive ...

Benitec Biopharma Inc. reports 100% responder rates for BB-301 with a mid-2026 FDA meeting ahead. See why BNTC stock is upgraded to buy.

Some people don’t develop dementia despite showing signs of Alzheimer’s disease in their brain, and we're starting to ...

Discover how a newly developed platform technology from The University of North Carolina at Chapel Hill can enhance RNAi ...

Yeast-based protein expression systems will likely play an important role in vaccine production during future pandemics.

Schizophrenia is a complex mental health disorder, but scientists are learning more about what can cause it... | Genetics And ...

Moderna and Merck's melanoma vaccine, combined with Keytruda, could halve cancer recurrence risk, marking a breakthrough in ...

United Therapeutics reported revenues of $799.5 million, up 6.8% year on year, falling short of analysts’ expectations by 1.6 ...

The power of artificial intelligence (AI) and advanced computing has made it possible to design genetic sequences encoding ...